If, during an audit, you are unable to demonstrate a reduction in AKI/CIN (Acute Kidney Injury/Contrast-Induced Nephropathy), the problem is often not a “lack of technology,” but rather a lack of workflow traceability. For Healthcare Management, this translates into a practical frustration: renal outcomes and costs exist, but without structured data they cannot be linked to contrast-media choices and the protocols adopted. The solution is to define a minimum set of KPIs and a procedure log that make the contrast-sparing/Zero Contrast pathway measurable, manageable, and reportable.
In many European healthcare facilities, including those in Italy, data are collected in “silos”: the angiography system records images and dose, the medical record stores creatinine values and diagnoses, the inventory system tracks consumption, and administrative flows record DRGs and length of stay. When an audit takes place, the causal and temporal link between the procedure, iodine exposure, protocol choice, and renal outcome is missing.
The result is predictable: even if the clinical team has introduced CO₂ or contrast-sparing strategies, Healthcare Management cannot robustly demonstrate that the change has reduced AKI/CIN, readmissions, or avoidable costs. Without standard traceability, the issue becomes a matter of opinion rather than governance.
Workflow traceability is the ability to reconstruct a complete “data story” for each procedure: who did what, with which parameters, in which patient, and with what outcomes. It is not a bureaucratic exercise: it is what makes it possible to turn renal preservation into a measurable quality and safety program.
In practice, this means having a procedure log that links technical parameters, such as injections, volumes, and timing, to clinical indicators, such as AKI/CIN, and process indicators, such as length of stay and readmissions. This is where digital standardization and repeatable training make a difference, because they reduce operator-dependent variability and make cases comparable.
To get started, a perfect data lake is not required. What is needed is a minimum, consistent, and stable dataset that the healthcare facility can maintain for 6–12 months. The goal is to answer three questions from Healthcare Management: how much iodine have we avoided, what renal outcome have we achieved, and what organizational and economic impact can be observed.
This dataset can be cited in an audit because it explicitly links inputs, such as the protocol and contrast choices, to outputs, such as AKI/CIN and care-pathway KPIs. It also enables periodic reporting for Risk Management, Clinical Governance, and Procurement.
“Iodine volume avoided” is a powerful but fragile indicator if no baseline is defined. The baseline must be local and transparent: for example, the median iodinated contrast volume for a specific procedure during the previous six months, stratified by complexity. Alternatively, a target volume can be defined for each protocol, agreed upon by the team (Interventional Radiology, Vascular Surgery, and Nephrology) and approved as an internal standard.
In an audit, credibility comes from two elements: a documented baseline and a consistent methodology. Perfection is not required; repeatability and verifiability are.
Healthcare Management assesses not only the clinical value of an innovation, but also its governability: the ability to control risk, measure effects, and report results. Digital standardization, including a traceable workflow, recorded parameters, and repeatable protocols, reduces the “craft-based” approach that often limits CO₂ use and makes data comparable across teams, shifts, and sites.
Training is the other pillar: without education, even the best protocol produces variability, exceptions, and data that are difficult to interpret. Structured programs, such as workshops, mentoring, and operational checklists, make procedures more consistent and KPIs more stable over time. In this context, solutions such as Angiodroid automatic systems for CO₂ angiography support the repeatability and traceability required for audits and governance.
Select 1–3 types of procedures below the diaphragm and define a local baseline for iodinated contrast volumes (median/percentiles), together with a shared definition of AKI/CIN. Document the methodology and obtain approval through Clinical Governance so that it can be audited.
Create a single template, either digital or integrated into the medical record, that collects injection parameters, iodine volume used/residual volume, reasons for exceptions, and pre-/post-procedure creatinine/eGFR data. The goal is to create a unique link between the procedure, contrast exposure, and renal outcome.
Report the following every month: percentage of contrast-sparing/Zero Contrast cases, mean iodine volume and iodine avoided, AKI/CIN incidence, LOS, and readmissions. Discuss deviations and variability between operators, then update protocols and training to improve the quality and stability of results.
It is difficult because structured data are often missing that link, for each procedure, the choice of contrast medium and technical parameters to the renal outcome. Data are scattered across the medical record, angiography system, inventory system, and administrative flows. Without a standard procedure log, the audit cannot verify the relationship between the protocol and AKI/CIN.
The KPIs should cover iodine exposure, renal outcomes, and care-pathway impact: iodine volume used and avoided, AKI/CIN incidence based on pre-/post-procedure creatinine/eGFR, LOS, and 30-day readmissions. Adding protocol adherence and variability between operators is useful for true governance. A small but stable dataset is more auditable than a broad but incomplete one.
It is calculated by comparing the iodinated contrast volume used during the procedure with a documented local baseline, for example the median volume used for that procedure during the previous six months, stratified by complexity. Alternatively, a target volume defined in an approved internal protocol can be used. Credibility depends on the transparency of the baseline and the consistency of the methodology over time.
No. CO₂ is a clinical lever, but reporting requires workflow traceability and standardization. Without a procedure log and KPIs, CO₂ adoption cannot be linked to reductions in AKI/CIN, LOS, or readmissions. Digital standardization and training make data comparable and therefore usable in audits and governance.
The first step is to limit the scope to a small number of procedures and implement a single log template with essential fields, including injection parameters, iodine used, pre-/post-procedure creatinine/eGFR, and LOS. Then produce a monthly report covering 5 KPIs for 6 months, correcting exceptions and variability along the way. This “minimum but stable” approach creates operational evidence without burdening the clinical workflow.
A question for you: can you currently reconstruct, for every procedure, how much iodine was used, why it was used, and what renal outcome was observed within 72 hours? If the answer is “not always,” you have already identified the real bottleneck.
Share in the comments which 2 KPIs are already available in your healthcare facility and which 2 are missing. We will reply with a proposed minimum dataset and a baseline approach suitable for a real-world audit in Italy or elsewhere in Europe.